507 related articles for article (PubMed ID: 27974318)
21. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
Bianchi S; Bigazzi R; Campese VM
Kidney Int; 2006 Dec; 70(12):2116-23. PubMed ID: 17035949
[TBL] [Abstract][Full Text] [Related]
22. Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies.
Fathallah-Shaykh SA
Pediatr Nephrol; 2017 May; 32(5):743-751. PubMed ID: 27350622
[TBL] [Abstract][Full Text] [Related]
23. Renal function changes after fenestrated endovascular aneurysm repair.
Tran K; Fajardo A; Ullery BW; Goltz C; Lee JT
J Vasc Surg; 2016 Aug; 64(2):273-280. PubMed ID: 27237402
[TBL] [Abstract][Full Text] [Related]
24. Three-year outcomes after acute kidney injury: results of a prospective parallel group cohort study.
Horne KL; Packington R; Monaghan J; Reilly T; Selby NM
BMJ Open; 2017 Mar; 7(3):e015316. PubMed ID: 28360257
[TBL] [Abstract][Full Text] [Related]
25. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
[TBL] [Abstract][Full Text] [Related]
26. The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review.
Collister D; Ferguson T; Komenda P; Tangri N
Semin Nephrol; 2016 Jul; 36(4):273-82. PubMed ID: 27475658
[TBL] [Abstract][Full Text] [Related]
27. Aldosterone blockade in chronic kidney disease.
Hirsch JS; Drexler Y; Bomback AS
Semin Nephrol; 2014 May; 34(3):307-22. PubMed ID: 25016401
[TBL] [Abstract][Full Text] [Related]
28. Antioxidants for chronic kidney disease.
Jun M
Nephrology (Carlton); 2013 Aug; 18(8):576-8. PubMed ID: 23865542
[No Abstract] [Full Text] [Related]
29. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome.
Chawla LS; Kimmel PL
Kidney Int; 2012 Sep; 82(5):516-24. PubMed ID: 22673882
[TBL] [Abstract][Full Text] [Related]
30. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
Ahmed AK; Kamath NS; El Kossi M; El Nahas AM
Nephrol Dial Transplant; 2010 Dec; 25(12):3977-82. PubMed ID: 19820248
[TBL] [Abstract][Full Text] [Related]
31. Extracellular microRNA signature in chronic kidney disease.
Muralidharan J; Ramezani A; Hubal M; Knoblach S; Shrivastav S; Karandish S; Scott R; Maxwell N; Ozturk S; Beddhu S; Kopp JB; Raj DS
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F982-F991. PubMed ID: 28077372
[TBL] [Abstract][Full Text] [Related]
32. Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny.
Gentile G; Remuzzi G; Ruggenenti P
Nephron; 2015; 129(1):39-41. PubMed ID: 25531311
[TBL] [Abstract][Full Text] [Related]
33. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
Chen PM; Wada T; Chiang CK
Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
[TBL] [Abstract][Full Text] [Related]
35. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.
Warady BA; Abraham AG; Schwartz GJ; Wong CS; Muñoz A; Betoko A; Mitsnefes M; Kaskel F; Greenbaum LA; Mak RH; Flynn J; Moxey-Mims MM; Furth S
Am J Kidney Dis; 2015 Jun; 65(6):878-88. PubMed ID: 25799137
[TBL] [Abstract][Full Text] [Related]
37. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
[TBL] [Abstract][Full Text] [Related]
38. Long-term fate of renal function after open surgery for juxtarenal and pararenal aortic aneurysm.
Sugimoto M; Takahashi N; Niimi K; Kodama A; Banno H; Komori K
J Vasc Surg; 2018 Apr; 67(4):1042-1050. PubMed ID: 28964618
[TBL] [Abstract][Full Text] [Related]
39. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
40. Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial.
Wu MT; Tung SC; Hsu KT; Lee CT
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):271-7. PubMed ID: 23223162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
